A Study of Intravenous Mircera for the Correction of Anemia in Dialysis Patients.

NCT00546481 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia

Interventions

DRUG: methoxy polyethylene glycol-epoetin beta [RO0503821, Mircera]
DRUG: Epoetin

Sponsor

Hoffmann-La Roche